InceptionR’s NRC Health Common Stock NRC Stock Holding History

InceptionR’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,541	Closed	-$239K	–	741
2024 Q4	$239K	Buy	+13,541	New	+$257K	0.05%	525

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

InceptionR's NRC Position: Q1 2025 in Review

InceptionR sold out of NRC Health Common Stock (NRC) in Q1 2025, closing a stake of 13,541 shares — an estimated $239K sold.

InceptionR first reported a position in NRC in Q4 2024 and held it in 1 quarter. The position peaked at $239K in Q4 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q1 2025.

InceptionR reported no remaining NRC Health Common Stock position as of Q1 2025 after selling out during the quarter.
InceptionR sold 13,541 NRC Health Common Stock shares in Q1 2025, an estimated $239K.
InceptionR first reported a position in NRC Health Common Stock in Q4 2024 and held it in 1 quarter.
InceptionR's NRC Health Common Stock position peaked at $239K in Q4 2024.
123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2025.

Based on InceptionR's 13F filing for Q1 2025, filed 12 May 2025.